PharmAust raises stake to 51% in JV with Curtin University
PharmAust is a unit of Epichem that contributed cash to the university to gain an additional 11% in the JV, proactiveinvestors.com.au reported. It is believed that the treatment
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.